Review Article |
| Huntington Study Group (Anderson KE, primary author). Comorbidities of obsessive and compulsive symptoms in Huntington's disease. Journal of Nervous and Mental Disease 198:334-338,2010. | 2010 |
| Huntington Study Group (Beglinger LJ, primary author). Earliest functional declines in Huntington disease. Psychiatry Research 178:414-418,2010. | 2010 |
| Narashimhalu K, Ang S, De Silva DA, Wong MC, Chang HM, Chia KS, Auchus AP, Chen C. The prognostic effects of post stroke CIND and domain specific cognitive impairments. Stroke 2010 (in press). | 2010 |
Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM Alzheimer's Disease Neuroimaging
Initiative. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Human Brain Mapping 30:2766-2788,2009. | 2009 |
| McEvoy LK, Fennema-Notestine C, Roddey JC, Hagler DJ Jr, Holland D, Karow DS, Pung CJ, Brewer JB, Dale AM Alzheimer's Disease Neuroimaging Initiative. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 251:195-205,2009. | 2009 |
| Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, Jack CR Jr, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Borowski B, Shaw LM, Trojanowski JQ, Fleisher AS, Harvey D, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM Alzheimer's Disease Neuroimaging Initiative. Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. NeuroImage 45:645-655,2009 | 2009 |
| Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, Jack CR Jr, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Borowski B, Shaw LM, Trojanowski JQ, Fleisher AS, Harvey D, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM Alzheimer's Disease Neuroimaging Initiative. Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. NeuroImage 45:645-655,2009. | 2009 |
| Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM Alzheimer's Disease Neuroimaging Initiative. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. NeuroImage 45(Suppl 1):S3-S15,2009. | 2009 |
| Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL, Weiner MW, Koeppe RA, Jagust WJ, Reiman EM Alzheimer's Disease Neuroimaging Initiative. Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage 45:1107-1116,2009. | 2009 |
| Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Annals of Neurology 65:403-413, 2009. | 2009 |
Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ Alzheimer's Disease Neuroimaging Initiative. Episodic memory loss is
related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 132:1310-1323,2009. | 2009 |
| Chupin M, Gérardin E, Cuingnet R, Boutet C, Lemieux L, Lehéricy S, Benali H, Garnero L, Colliot O Alzheimer's Disease Neuroimaging Initiative. Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI. Hippocampus 19:579-587,2009. | 2009 |
| Chou YY, Leporé N, Avedissian C, Madsen SK, Parikshak N, Hua X, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM Alzheimer's Disease Neuroimaging Initiative. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. NeuroImage 46:394-410, 2009. | 2009 |
| Chou YY, Leporé N, Avedissian C, Madsen SK, Parikshak N, Hua X, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM Alzheimer's Disease Neuroimaging Initiative. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. NeuroImage 46:394-410, 2009. | 2009 |
| Chou YY, Leporé N, Avedissian C, Madsen SK, Parikshak N, Hua X, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM Alzheimer's Disease Neuroimaging Initiative. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage 46:394-410,2009. | 2009 |
| Qiu A, Fennema-Notestine C, Dale AM, Miller MI Alzheimer's Disease Neuroimaging Initiative. Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease. NeuroImage 45:656-661,2009. | 2009 |
| Qiu A, Fennema-Notestine C, Dale AM, Miller MI Alzheimer's Disease Neuroimaging Initiative. Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease. NeuroImage 45:656-661,2009. | 2009 |
| Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC Alzheimer's Disease Neuroimaging Initiative. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 132:1355-1365,2009. | 2009 |
| Fennema-Notestine C, Hagler DJ Jr, McEvoy LK, Fleisher AS, Wu EH, Karow DS, Dale AM Alzheimer's Disease Neuroimaging Initiative. Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Human Brain Mapping 30:3238-3253,2009. | 2009 |
| Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM Alzheimer's Disease Neuroimaging Initiative. Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. NeuroImage 43:59-68,2008. Erratum in: NeuroImage 44:1439,2009. | 2009 |
| Huang A, Abugharbieh R, Tam R Alzheimer’s Disease Neuroimaging Initiative. A hybrid geometric-statistical deformable model for automated 3-D segmentation in brain MRI. IEEE Transactions on Biomedical Engineering 56:1838-1848,2009. | 2009 |
| Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR Jr, Weiner MW Disease Neuroimaging Initiative. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain 132:1067-1077, 2009. | 2009 |
| Narashimhalu K, Ang S, De Silva DA, Wong MC, Chang HM, Chia KS, Auchus AP, Chen C. Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort. Neurology 73:1866-1872,2009. | 2009 |
| Holland D, Brewer JB, Hagler DJ Subregional neuroanatomical change as a biomarker for Alzheimer’s disease. Proceeding of the National Academy of Sciences 106:20954-20959,2009. | 2009 |
| Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, Chou YY, Brun C, Chiang MC, Barysheva M, Jack CR Jr, Bernstein MA, Britson PJ, Ward CP, Whitwell JL, Borowski B, Fleisher AS, Fox NC, Boyes RG, Barnes J, Harvey D, Kornak J, Schuff N, Boreta L, Alexander GE, Weiner MW, Thompson PM Alzheimer's Disease Neuroimaging Initiative. 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. NeuroImage 41:19-34,2008. | 2008 |
| Boyes RG, Gunter JL, Frost C, Janke AL, Yeatman T, Hill DL, Bernstein MA, Thompson PM, Weiner MW, Schuff N, Alexander GE, Killiany RJ, DeCarli C, Jack CR, Fox NC Alzheimer's Disease Neuroimaging Initiative. Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. NeuroImage 39:1752-1762,2008. | 2008 |
| Fan Y, Batmanghelich N, Clark CM, Davatzikos C Alzheimer's Disease Neuroimaging Initiative. Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. NeuroImage 39:1731-1743,2008. | 2008 |
| Hua X, Leow AD, Parikshak N, Lee S, Chiang MC, Toga AW, Jack CR Jr, Weiner MW, Thompson PM Alzheimer's Disease Neuroimaging Initiative. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. NeuroImage 43:458-469,2008. | 2008 |
| Frisoni GB, Henneman WJ, Weiner MW, Scheltens P, Vellas B, Reynish E, Hudecova J, Hampel H, Burger K, Blennow K, Waldemar G, Johannsen P, Wahlund LO, Zito G, Rossini PM, Winblad B, Barkhof F Alzheimer's Disease Neuroimaging Initiative. The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimer’s & Dementia 4:255-264,2008. | 2008 |
| Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R Alzheimer's Disease Neuroimaging Initiative. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 131:2443-2454,2008 | 2008 |
| Narasimhalu K, Lee J, Auchus AP, Chen CPLH Improving detection of dementia in Asian patients with low education: combining the Mini-Mental State Examination and the Informant Questionnaire on Cognitive Decline in the Elderly. Dementia and Geriatric Cognitive Disorders 25:17-22,2008. | 2008 |
| Huang J and Auchus AP. Diffusion tensor imaging of normal appearing white matter and its correlation with cognitive functioning in mild cognitive impairment and Alzheimer's disease. Annals of the New York Academy of Sciences 1097:259-264,2007. | 2007 |
| Huang J, Friedland RP, Auchus AP. Diffusion tensor imaging of normal appearing white matter in MCI and early AD: preliminary evidence of axonal degeneration in temporal lobe. American Journal of Neuroradiology 28:1943-1948,2007. | 2007 |
| Huntington Study Group (Langbehn DR, primary author). Predictors of diagnosis in Huntington's disease. Neurology 68:1710-1717,2007. | 2007 |
| Auchus AP, Brashear HR, Salloway S, Korczyn AD, De Deyn PP, Gassmann-Mayer C. Galantamine Treatment of vascular dementia: a randomized trial. Neurology 69:448-458,2007. | 2007 |
| Tay SY, Ampil ER, Chen CPLH, Auchus AP. The relationship between homocysteine, cognition and stroke subtypes in acute stroke. Journal of the Neurological Sciences 250:58-61,2006. | 2006 |
| Ampil ER, Fook-Chong S, Sodagar SN, Chen CPLH, Auchus AP Ethnic variability in dementia: results from Singapore. Alzheimer Disease and Associated Disorders 19:184-185,2005. | 2005 |
| Tan EK, Chan LL, Auchus AP Hemidystonia precipitated by acute pontine infarct. Journal of the Neurological Sciences 234(1-2):109-111,2005. | 2005 |
| Huntington Study Group (Nahant N, primary author). Huntington's disease: clinical correlates of disability and progression. Neurology 61:1085-1092,2003 | 2003 |
Auchus AP, Chen CPLH International Working Group for the Harmonization of Dementia Drug Guidelines. 2nd Asia-Pacific regional meeting of the international working group on harmonization of
dementia drug guidelines: meeting report. Alzheimer Disease and Associated Disorders 17:129-131,2003. | 2003 |
| Lim CCT, Lee WL, Leo YS Late clinical and magnetic resonance imaging follow-up of the Nipah virus infection. Journal of Neurology, Neurosurgery & Psychiatry 74:131-133,2003. | 2003 |
| Huntington Study Group (Wheelock VL, primary author). Predictors of nursing home placement in Huntington's disease. Neurology 60:998-1001,2003. | 2003 |
| Tan EK, Chan LL, Auchus AP, Wong MC Reversible choreoathetosis in primary cerebral lymphoma: clinicoradiological correlation. European Neurology 50:53-54,2003. | 2003 |
| Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey. Parkinsonism & Related Disorders 8:277-284,2002. | 2002 |
| Lim CC, Lee KE, Lee WL Nipah virus encephalitis: serial MR study of an emerging disease. Radiology 222:219-226,2002. | 2002 |
| Koh YT, Auchus AP, Chen CPLH, Tan EK Prevalence of neuropsychological problems in Parkinson’s disease. SGH Proceedings 11:259-263,2002 | 2002 |
| Tham W, Auchus AP, Thong M Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients Journal of the Neurological Sciences 203-204:49-52,2002. | 2002 |
| Tham W, Auchus AP, Thong M Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. Journal of the Neurological Sciences 203-204:49-52,2002 | 2002 |
| Tham W, Auchus AP, Thong M Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. Journal of the Neurological Sciences 203-204:49-52,2002. | 2002 |
| Tham W, Auchus AP, Thong M Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. ournal of the Neurological Sciences 203-204:49-52,2002. | 2002 |
| Auchus AP, Chen CPLH, Sodagar SN, Thong M, Sng ECS Single stroke dementia: insights from 12 cases in Singapore. Journal of the Neurological Sciences 203-204:85-89,2002 | 2002 |
| Auchus AP, Chen CPLH Asia-Pacific Consensus Conference Representatives. Asia-Pacific Consensus Statement on dementia Alzheimer Disease and Associated Disorders 15:63-65,2001. | 2001 |
| Tan EK, Chan LL, Auchus AP Complex movement disorders following bilateral paramedian thalamic and bilateral cerebellar infarcts. Movement Disorders 16:968-970,2001 | 2001 |
| Auchus AP, Chen CPLH International Working Group for the Harmonization of Dementia Drug Guidelines. Asia regional meeting of the international working group for the harmonization of dementia drug guidelines: meeting report. Alzheimer Disease and Associated Disorders 15:66-68,2001 | 2001 |
| Tan EK, Lo YL, Seah A, Auchus AP Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea for amyotrophic lateral sclerosis Journal of the Neurological Sciences 190:95-97,2001 | 2001 |
| Tan EK, Chan LL, Auchus AP. Reversible parkinsonism in systemic lupus erythematosus Journal of the Neurological Sciences 193:53-57,2001. | 2001 |
| Teri L, Logsdon RG, Peskind E Treatment of agitation in AD: a randomized, placebo-controlled clinical trial Neurology 55:1271-1278,2000. | 2000 |
| Paton NI, Yee SL, Zaki SR Outbreak of Nipah-virus infection among abattoir workers in Singapore Lancet 354:1253-1256,1999 | 1999 |
| Woodard JL, Auchus AP, Godsall RE, Green RC An analysis of test bias and differential item functioning due to race on the Mattis Dementia Rating Scale of Gerontology: Psychological Sciences 53:370-374,1998. | 1998 |
| Huntington Study Group (Marshall F, primary author) Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease. Neurology 50:1366-1373,1998 | 1998 |
| Auchus AP Dementia in urban black outpatients: initial experience at the Emory satellite clinics The Gerontologist 37:25-29,1997. | 1997 |
| Farrer LA, Cupples LA, Haines JL Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis JAMA 278:1349-1356,1997 | 1997 |
| Auchus AP and Bissey-Black C Pilot study of haloperidol, fluoxetine and placebo for agitation in Alzheimer's disease Journal of Neuropsychiatry and Clinical Neuroscience 9:591-593,1997. | 1997 |
| AGS Ethnogeriatrics Advisory Committee. Ethnogeriatrics: a position paper from the American Geriatrics Society. Journal of the American Geriatrics Society 44:326-327,1996. | 1996 |
| Huntington Study Group (Kieburtz K, primary author) Unified Huntington's disease rating scale: reliability and consistency Movement Disorders 11:136-142,1996. | 1996 |
| Auchus AP, Freeman A, Green RC. Agitated behavior relieved following treatment of cervical dystonia in dementia Neurology 45:393,1995. | 1995 |
| Auchus AP, Green RC, Nemeroff CB. Cortical and subcortical neuropeptides in Alzheimer's disease. Neurobiology of Aging 15:589-595,1994. | 1994 |
| Auchus AP, Goldstein FC, Green J, Green RC. Unawareness of cognitive impairments in Alzheimer's disease Neuropsychiatry, Neuropsychology, and Behavioral Neurology 7:25-29,1994. | 1994 |
| Auchus AP and Pickel VM. Quantitative light microscopic demonstration of increased pallidal and striatal met5-enkephalin-like immunoreactivity in rats following chronic treatment with haloperidol, but not with clozapine: implications for the pathogenesis of neuroleptic induced movement disorders. Experimental Neurology 117:17-27,1992 | 1992 |
| Green RC, Goldstein FC, Auchus AP Treatment trial of oxiracetam in Alzheimer’s disease. Archives of Neurology 49:1135-1136,1992. | 1992 |
| Herscovitch P, Auchus AP, Gado M, Chi D, Raichle ME. Correction of positron emission tomography data for cerebral atrophy Journal of Cerebral Blood Flow and Metabolism 6:120-124,1986. | 1986 |
Abstracts |
| Huang J, Friedland RP, Tkach J, Auchus AP Altered intra- and inter-hemispheric fiber connections in agenesis of the corpus callosum: a case report. Journal of Neuroimaging 19:105-106,2009 | 2009 |
| Huang J and Auchus AP. Lobar gray and white matter atrophy in Alzheimer’s disease: preliminary results from the ADNI public database. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 4(Suppl 2):T371-T372,2008. | 2008 |
| Huang J and Auchus AP. Lobar gray and white matter atrophy in Alzheimer’s disease: preliminary results from the ADNI public database. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 4(Suppl 2):T81,2008. | 2008 |
| Auchus AP and Huang J. Lobar gray matter atrophy in Alzheimer's disease. Journal of Neuroimaging 18:211,2008. | 2008 |
| Auchus AP and Huang J. Mean diffusivity in normal appearing frontal white matter as a preclinical biomarker for vascular cognitive impairment. Journal of the Neurological Sciences 2008. | 2008 |
| Auchus AP and Huang J. Auchus AP and Huang J. Diffusion tensor imaging of normal appearing white matter in AD and MCI. Neurology 68(Suppl 1):A273,2007. | 2007 |
| Huang J and Auchus AP. Cognitive and functional relevance of white matter integrity in MCI and AD. Journal of Neuropsychiatry and Clinical Neuroscience 19:230-231,2007. | 2007 |
| Huang J and Auchus AP. Diffusion tensor imaging of normal and abnormal appearing white matter in the frontal lobes of mild cognitive impairment and Alzheimer's disease. Journal of Neuroimaging 17:94-95,2007. | 2007 |
| Auchus AP and Huang J. Diffusion tensor imaging of normal appearing white matter in AD and MCI Neurology 68(Suppl 1):A273,2007. | 2007 |
| Lerner A, Friedland RP, McClendon MJ, Auchus AP. Comparison of demographics and referral source of African-American cases and controls in a longitudinal study of Alzheimer’s disease. Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association 2(Suppl 1):146,2006. | 2006 |
| Huang J and Auchus AP. Diffusion tensor imaging of normal appearing white matter in MCI and AD. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 2(Suppl 1):335,2006. | 2006 |
| Huang J and Auchus AP. Diffusion tensor imaging of normal appearing white matter in MCI and AD. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 2(Suppl 1):680,2006. | 2006 |
| Auchus AP, van Straaten I, Wong LKS, Chen CLH, Scheltens P. Ethnic differences in vascular dementia subtypes. Journal of the Neurological Sciences 226:121,2004. | 2004 |
| Ampil ER, Chen CLH, Auchus AP. Impaired cognitive domains in different vascular dementia subtypes correlated with cranial MRI abnormalities. Journal of the Neurological Sciences 226:138,2004. | 2004 |
| Goh CS, Auchus AP, Chen CLH. Neuropsychological correlates in the differentiation of probable Alzheimer disease and subcortical ischemic vascular dementia. Journal of the Neurological Sciences 226:106,2004. | 2004 |
| Lim G, Auchus AP, Chen CLH. Progression of cognitive impairment after stroke: two-year results from a longitudinal study of Singaporean stroke patients. Journal of the Neurological Sciences 226:108,2004. | 2004 |
| Auchus AP, Brashear HR, Salloway S, Scheltens P, Korczyn AD, Gassmann-Mayer C, Gold M. Results of a trial of galantamine in subjects with vascular dementia confirmed by central MRI reading. Neurology 63:1548,2004. | 2004 |
| Tay SY, Auchus AP, Chen CLH. The relationship between homocysteine, cognition, and stroke subtypes in acute stroke. Journal of the Neurological Sciences 226:135,2004. | 2004 |
| Wong MC, Yu GX, Ng YK, Fook-Chong S, Chang HM, Chen CPLH, Auchus AP, Ling EA, Wilder-Smith E. Microvascular endothelial “blebbing”: an in vivo study of stroke patients. Neurology 60(Suppl 1):A63,2003. | 2003 |
| Auchus AP, Chen CPLH, Wilder-Smith E, Yu GXE, Wong MC. Microangiopathic dementia: a case report from Singapore. Icelandic Medical Journal 88(Suppl 43):40,2002. | 2002 |
| Chen CP, Tham W, Auchus AP, Thong M, Chang HM, Goh ML. Risk factors for progression of cognitive impairment after stroke: a longitudinal study in Singaporean stroke patients. Cerebrovascular Diseases 13(Suppl 3):69,2002. | 2002 |
| Auchus AP, Chen CPLH, Han V, Thong M. Cortical and subcortical dementia in Singapore. Neurology 56(Suppl 3):A173,2001. | 2001 |
| Wilder-Smith E, Wong MC, Xu M, Chen C, Auchus A, Ling EA. Endothelial blebbing: a marker for vascular cognitive impairment. Cerebrovascular Diseases 11(Suppl 4):105,2001 | 2001 |
| Han V, Chen P, Yeo D, Thong M, Govindan A, Auchus A, Chen C. A vascular dementia battery for Singaporeans. Stroke 31:2803,2000. | 2000 |
| Huntington Study Group (Hogarth P, primary author). A study of inter-rater reliability of the motor diagnosis of Huntington’s disease. Movement Disorders 14:901,1999. | 1999 |
| Huntington Study Group (Volk M, primary author). Electrocardiographic manifestations of Huntington's disease. Movement Disorders 14:902,1999. | 1999 |
| Huntington Study Group (Marder KS, primary author). Huntington Study Group (Marder KS, primary author). Rate of functional decline in Huntington's disease Neurology 52(Suppl 2):A376,1999. | 1999 |
| Auchus AP and Lynn MJ Multiple Etiology Dementia in African-Americans. Neurobiology of Aging 19(Suppl 4):S169,1998. | 1998 |
| Marshall FJ, Taylor S and the Huntington Study Group Aggression and irritability in Huntington disease: a survey of treatment patterns. Neurology 48:A49,1997. | 1997 |
| Simpson SR, Auchus AP, McDonald WM, Woodard JL, Redd RB. Effects of white matter hyperintensities on neuropsychiatric symptoms in patients with Alzheimer's disease. American Psychiatric Association Abstracts 85,1997. | 1997 |
| Auchus AP and Bissey-Black C Haloperidol vs. fluoxetine vs. placebo for agitation in Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neuroscience 9:171,1997 | 1997 |
| Auchus AP and Lynn MJ. Is hypertension a risk factor for vascular dementia in American blacks? Ethnicity & Disease 7(Suppl):S21, 1997. | 1997 |
| Auchus AP and Woodard JL. Risk factors for vascular dementia of the Neurological Sciences 150 (Suppl):S17,1997. | 1997 |
| Simpson SR, Woodard JL, Auchus AP. The effects of diabetes mellitus on the neuropsychiatric features of Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neuroscience 9:180,1997 | 1997 |
| Swaringen J, Auchus A, Woodard J. The relationship between intellectually stimulating activities and cognitive decline in Alzheimer's disease. Journal of the American Geriatrics Society 45:S18,1997 | 1997 |
| Woodard JL, Auchus AP, Godsall RE. Cultural performance differences on the Mattis Dementia Rating Scale. The Clinical Neuropsychologist 10:331,1996. | 1996 |
| Huntington Study Group (Marshall FJ, primary author). Inter-laboratory variability of (CAG)n determinations in Huntington's disease (HD). Neurology 46:A258,1996. | 1996 |
| Huntington Study Group (Como PG, primary author). Neuropsychological assessment in multicenter clinical trials. Journal of the International Neuropsychological Society 2:44,1996 | 1996 |
| Huntington Study Group (Bylsma FW, primary author). Noncognitive symptoms in Huntington's disease. Journal of the International Neuropsychological Society 2:35,1996. | 1996 |
| Auchus AP, Woodard JL, Simpson SR. Risk factors for agitation in patients with Alzheimer's disease. Journal of the American Geriatrics Society 44:S58,1996 | 1996 |
| Auchus AP, Woodard JL, Simpson SR Risk factors for agitation in patients with Alzheimer's disease. Journal of the American Geriatrics Society 44:S58,1996 | 1996 |
| Huntington Study Group (Marshall FJ, primary author). Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease. Movement Disorders 11(Suppl 1):59,1996. | 1996 |
| Goldstein FC, Roberts VJ, Auchus AP, Woodard JL, Green RC Symmetrical and asymmetrical presentations of apraxia in Alzheimer's disease. Journal of the International Neuropsychological Society 2:61,1996. | 1996 |
| Huntington Study Group (Paulsen JS, primary author). The clinical utility of the Stroop Test A in a multicenter study of Huntington's disease. Journal of the International Neuropsychological Society 2:35,1996. | 1996 |
| Jacobs EVS, Woodard JL, Auchus AP African-Americans' attitudes toward clinical research. Journal of the American Geriatrics Society 43:1331,1995. | 1995 |
| Auchus AP, Woodard JL, Murray VF Combination dementias in African-Americans at the Emory Alzheimer's disease satellite clinic. The Gerontologist 35:347,1995. | 1995 |
| Olson DA, Green RC, Bakay RAE, Auchus AP, Mirra SS Diagnostic brain biopsy in atypical dementia. Journal of Neuropsychiatry and Clinical Neuroscience 7:406,1995. | 1995 |
| Redd R, Auchus AP, Woodard JL Effects of hypertension on Alzheimer's disease in African-Americans. Neurology 45(Suppl 4):A172,1995 | 1995 |
| Huntington Study Group (Como PG, primary author) Internal validity and consistency of the Unified Huntington's Disease Rating Scale (UHDRS). Neurology 45(Suppl 4):A254,1995 | 1995 |
| Auchus AP, Woodard JL, Simpson SR Risk factors for agitation in patients with dementia. Journal of Neuropsychiatry and Clinical Neuroscience 7:409,1995. | 1995 |
| Auchus AP, Murray VF, Green RC Clinical characteristics of African-American outpatients with Alzheimer's disease. Neurobiology of Aging 15(Suppl 1):S8,1994. | 1994 |
| Auchus AP and Figiel GS Safe and successful use of ECT to control agitation in an elderly man with dementia. Journal of Neuropsychiatry and Clinical Neuroscience 6:322,1994. | 1994 |
| Strasser D, Whittington F, Miller S, Auchus A. The ecology of a nursing home 1988-94: findings from a multimodal inquiry of restraint use. The Gerontologist 34:381-382,1994 | 1994 |
| Auchus AP and Woodard JL Dementia in urban African-Americans. Journal of the American Geriatrics Society 41(Suppl):SA35,1993. | 1993 |
| Auchus AP, Goldstein FC, Green RC Unawareness of cognitive impairments in Alzheimer's disease. Neurology 42(Suppl 3):224,1992 | 1992 |
| Auchus AP and Pickel VM Chronic haloperidol and clozapine differentially alter the density of met5-enkephalin-like immunoreactive perikarya in rat caudate versus accumbens nuclei. for Neuroscience Abstracts 16:587,1990. | 1990 |
| Auchus AP and Pickel VM Chronic haloperidol and clozapine differentially alter the density of met5-enkephalin-like immunoreactive perikarya in rat caudate versus accumbens nuclei. for Neuroscience Abstracts 16:587,1990. | 1990 |
| Auchus AP and Pickel VM Chronic haloperidol and clozapine differentially alter the density of met5-enkephalin-like immunoreactive perikarya in rat caudate versus accumbens nuclei. Society for Neuroscience Abstracts 16:587,1990. | 1990 |